Parataxis Korea, Inc. (KOSDAQ:288330)
South Korea · Delayed Price · Currency is KRW 1,249.00
+157.00 (14.38%)
At close: Jan 27, 2026
Parataxis Korea Revenue
Parataxis Korea had revenue of 10.10M KRW in the twelve months ending September 30, 2025, up 834.35% year-over-year. In the year 2024, Parataxis Korea had annual revenue of 2.18M, down -97.82%.
Revenue (ttm)
10.10M
Revenue Growth
+834.35%
P/S Ratio
11,660.62
Revenue / Employee
480.84K
Employees
21
Market Cap
117.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.18M | -97.82M | -97.82% |
| Dec 31, 2023 | 100.00M | -2.92B | -96.69% |
| Dec 31, 2022 | 3.02B | 1.10B | 57.15% |
| Dec 31, 2021 | 1.92B | -4.42B | -69.65% |
| Dec 31, 2020 | 6.34B | -51.94B | -89.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CTCBIO | 132.76B |
| KoBioLabs | 71.83B |
| Cell Biotech | 50.65B |
| Choong Ang Vaccine Laboratory | 39.19B |
| CORESTEMCHEMON | 20.13B |
| BIO-FD&C | 18.82B |
| TegoScience | 6.15B |
| Quratis | 2.28B |